Bell Investment Advisors, Inc Dexcom Inc Transaction History

Bell Investment Advisors, Inc

$574 Million
Q2 2025

A detailed history of Bell Investment Advisors, Inc transactions in Dexcom Inc stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 105 shares of DXCM stock, worth $7,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105

Previous 76 38.16%

Holding current value

$7,161

Previous $5,000 80.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$59.83 - $87.57 $1,735 - $2,539	29 Added 38.16%	105 $9,000
Q1 2025 May 15, 2025	BUY	$67.74 - $90.75 $1,287 - $1,724	19 Added 33.33%	76 $5,000
Q4 2024 Feb 07, 2025	SELL	$65.68 - $81.01 $1,970 - $2,430	-30 Reduced 34.48%	57 $4,000
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $2,624 - $4,758	-41 Reduced 32.03%	87 $5,000
Q1 2024 May 08, 2024	BUY	$114.22 - $140.1 $913 - $1,120	8 Added 6.67%	128 $17,000
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $226 - $372	3 Added 2.56%	120 $14,000
Q3 2023 Nov 08, 2023	SELL	$86.06 - $137.93 $688 - $1,103	-8 Reduced 6.4%	117 $10,000
Q2 2023 Aug 09, 2023	SELL	$112.47 - $130.98 $3,261 - $3,798	-29 Reduced 18.83%	125 $16,000
Q1 2023 May 10, 2023	BUY	$104.0 - $122.92 $1,248 - $1,475	12 Added 8.45%	154 $17,000
Q4 2022 Feb 08, 2023	BUY	$84.98 - $122.67 $2,974 - $4,293	35 Added 32.71%	142 $16,000
Q3 2022 Nov 09, 2022	SELL	$76.35 - $94.18 $1,450 - $1,789	-19 Reduced 15.08%	107 $9,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $6,187 - $12,092	91 Added 260.0%	126 $9,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $389 - $488	3 Added 9.38%	35 $19,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $3,414 - $4,581	32 New	32 $17,000

Others Institutions Holding DXCM

# of Institutions

1,109

Shares Held

367M

Call Options Held

5.36M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.

Account

Bell Investment Advisors, Inc Dexcom Inc Transaction History